Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with hypertrophic cardiomyopathy (a condition where the heart muscle becomes abnormally thick) and are willing to give their consent to take part in the registry.
- Family members of people diagnosed with hypertrophic cardiomyopathy who are willing to give their consent to take part in the registry.
Who may not be able to join:
- Anyone who does not wish to give their consent to participate in the registry program.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of HCM in Egypt; Determinants of clinical severity of HCM in Egypt; Determinants of cardiac phenotype severity of HCM in Egypt; Determinant of genotype severity of HCM in Egypt; Study the basic mechanisms responsible for the HCM in Egypt
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.